Albert Bourla
Chairman and Chief Executive Officer · Pfizer
Compiled from public sources. This person has not claimed this profile. Listing does not imply membership, endorsement or availability for meetings.
Veterinarian and pharmaceutical executive who has spent more than three decades at Pfizer, becoming CEO in 2019 and Chairman in 2020. His tenure has combined large-scale vaccine commercialization with a strategic shift toward oncology and next-generation medicines. Geographic context: United States / Greece-born.
Davos status
No verified 2027 attendance claim is available.
Last verified: 11 September 2026
Sources & verification
- https://www.weforum.org/podcasts/agenda-dialogues/episodes/davos-2026-global-economic-outlook/
- https://www.pfizer.com/people/leadership/executives/dr-albert_bourla
- Recorded research sources. Historical references do not confirm Davos 2027 attendance.
Record last verified: 11 September 2026. Organiser and self-reported pages are labelled as such and are not independent verification.